Clinical Trial Update: Immunological Mechanisms of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis [Phase 2]

View source ↗

Summary

This clinical trial update summarizes the Phase 2 study examining hematopoietic stem cell transplantation in multiple sclerosis and its immunological mechanisms…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Hematopoietic stem cell transplantation

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Multiple Sclerosis | Phase 2 | Status: COMPLETED